Product Description: N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-derived growth factor receptor kinases. N-Deshydroxyethyl Dasatinib can be used in cancer and immune disease research[1][2].
Applications: Cancer-Kinase/protease
Formula: C20H22ClN7OS
References: [1]Shibata N, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017 Aug;108(8):1657-1666./[2]Thappali SR, et al. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study. Arzneimittelforschung. 2012 Dec;62(12):624-30.
CAS Number: 910297-51-7
Molecular Weight: 443.95
Compound Purity: 98.58
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : 55 mg/mL (ultrasonic)
Target: Drug Metabolite
English
Deutsch
